Fig. 1From: Long-term follow-up of dogs with leishmaniosis treated with meglumine antimoniate plus allopurinol versus miltefosine plus allopurinolClinical and laboratory scores for G1 and G2 dogs during the post-therapy follow-up period. The scores were recorded at baseline, then every three months for 24 months, and then at 28, 36, 48, 60 and 72 months. The data for (a) total score (clinical + IFAT score), (b) clinical score, and (c) IFAT score. Scores are reported as the average and standard deviationBack to article page